" Julpar" The annual meeting of the General Assembly is held
Ras Al -Khaimah, on April 23/ WAM/ Al Khaleej Pharmaceutical Company – Julphar, “a public joint stock company” held its annual public association meeting yesterday, at its headquarters in the Emirate of Ras Al Khaimah, in the presence of the Board of Directors, Executive Administration and shareholders, as well as representatives of the regulators.
During the meeting, the company reviewed the financial performance of the year ending December 31, 2024, which witnessed the company’s registration for strong financial performance.
The association approved the audited financial statements for the fiscal year 2024, and the appointment of the external auditor for the fiscal year 2025 was approved.
Julphar has strengthened its presence in the main markets in the Middle East and Africa, where it recorded 72 new products, through its manufacturing capabilities and maintained its operational flexibility by taking advantage of the diversity of its products.
Within the framework of its strategic expansion goals, the company affirmed its commitment to investment of 300 million dirhams in the project of establishing a new facility for manufacturing biological and injections sterile in the Kingdom of Saudi Arabia, in order to meet the increasing demand for specialized drugs and support the region’s vision to enhance local manufacturing and sustain the health care sector.
Sheikh Saqr bin Humaid Al Qasimi, Chairman of Julphar’s Board of Directors, said that the company is committed to serving millions of patients within various treatment fields, by focusing on growth, innovation, cooperation and geographical expansion that will allow achieving a sustainable positive impact in the health care sector, as well as leaving a clear imprint on the knowledge economy.
For his part, Basil Ziada, CEO of Julpar, said that the positive results of the company, whether in terms of sales, profit or monetary flow, are the basic stone and the most prominent incentive that drives the company to continue its transformation journey towards sustainable growth and increase the volume of business and manufacturing capabilities.
Julphar had previously announced that it has recorded revenues of 1.31 billion dirhams during the year 2024, achieving 2.7% growth on an annual basis.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
